Updated Date: Mon, 03 Aug 2020 00:00:00 EDT
Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment
Phase III study of drug in Crohn’s disease is ongoing
Combination therapy showed benefit in hard-to-treat cancer type
New government package will be worth £172m
Teva’s Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout esagonowsky Mon, 08/10/2020 – 11:12
FiercePharmaPolitics—After drug pricing tensions, industry pushes back at Trump’s ‘Buy American’ order esagonowsky Mon, 08/10/2020 – 09:42
Kodak’s $765 million manufacturing loan on the rocks as red flags multiply kblankenship Mon, 08/10/2020 – 09:20
Pfizer, Moderna and Gilead reputations climb on COVID-19 vaccine and treatment news, according to Harris Poll beth.bulik Sun, […]
